Myth Or Not Persistence Data For Kesimpta

Summary

Expert Perspectives: Administration of The treatment initiation conversation neurologists need to hear: Join experts and Novartis colleagues as they walk through the design and key findings of the pivotal We're breaking down what studies show about In this video I share brand new MS drug results, comparing a new B-cell killer I was recently asked to make a video explaining the interpretation of blood tests for people taking drugs which deplete ... Join Dr Ann Bass and real patients, Jamie-Lynn and Caylee, as they discuss the treatment-naïve patient Ofatumumab is a b-cell depleting agent which had two successful clinical trials for multiple sclerosis (ASCLEPIOS I and ...